{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Stop. Test. Rethink: The Thyroxine Turning Point \ud83d\udd04\ud83e\udde0\ud83d\udc8a","description":"&amp;nbsp; \ud83e\udde0\ud83d\udc8a Stop. Test. Rethink. &amp;nbsp; A compelling new study in JAMA shows that ~26% of adults \u226560 years can safely discontinue levothyroxine, maintaining normal thyroid function\u2014especially those on low doses (\u226450 \u03bcg\/day). &amp;nbsp; \ud83d\udcc9 No meaningful decline in quality of life \ud83d\udcca Clear dose-response signal \u26a0\ufe0f Raises concerns about lifelong overtreatment &amp;nbsp; The message is elegant: Not every prescription deserves permanence. &amp;nbsp; Time to reassess, deprescribe, and individualize\u2014particularly in our older patients. &amp;nbsp; #Thyroid #Endocrinology #Deprescribing #Geriatrics #PrecisionMedicine ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40822150\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/200681920"}